Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.

Gregory P Forlenza Laya Ekhlaspour Linda A DiMeglioLarry A FoxHenry RodriguezDorothy I ShulmanKevin B KaisermanDavid R LiljenquistJohn ShinScott W LeeBruce A Buckingham

Published in: Pediatric diabetes (2022)

At-home MiniMed™ 670G Auto Mode use by young children safely improved glycemic outcomes compared to two-week open-loop Manual Mode use. The improvements are similar to those observed in older children, adolescents and adults with T1D using the same system for the same duration of time.

Keyphrases

young adults
type diabetes
physical activity
glycemic control
study protocol
transcription factor
adipose tissue
metabolic syndrome
skeletal muscle